Iwabu, Masato
Okada-Iwabu, Miki
Yamauchi, Toshimasa
Kadowaki, Takashi
Article History
Received: 6 July 2015
Revised: 13 September 2015
Accepted: 29 September 2015
First Online: 3 December 2015
Competing interests
: TK is a part of the Advisory Panel in Takeda, Daiichi-Sankyo, Tanabe-Mitsubishi, Taisho, Boehringer Ingelheim, Novo, is also a Consultant in MSD, Boehringer Ingelheim. TK is also a part of Research Support in Chugai, MSD, Ono, Daiichi-Sankyo, Tanabe-Mitsubishi, Sanofi, Astra Zeneca, Takeda, Boehringer Ingelheim, Novo, Novartis and is also a part of Speaker's Bureau in Boehringer Ingelheim, Daiichi-Sankyo, Tanabe-Mitsubishi, Astellas, Takeda, Ono, Kowa, Astra Zeneca, Dainippon- Sumitomo, Sanwa, Taisho, Eli Lilly, Kowa, Kyowahakko Kirin, MSD, Novartis, Sanofi. TY provides Research Support in Novo, Astellas, Ono, Daiichi-Sankyo, Tanabe-Mitsubishi, Takeda and is a part of Speaker's Bureau in Boehringer Ingelheim, Daiichi-Sankyo, Tanabe-Mitsubishi, Astellas, Takeda, Ono, Kowa, Astra Zeneca, Taisho, Eli Lilly, Kyowahakko Kirin, MSD, Novo. The remaining authors declare no conflict of interest.